In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.

Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine 

Source Links: 

• Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference 

• ASCO: AstraZeneca\’s Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation 

• ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? 

• ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth 

• At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer 

• What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck 

• Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up 

• Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up 

• ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine 

• Moderna And Merck Advance Cancer Treatment With Promising Vaccine 

• NHS patients in England to be offered trials for world-first cancer vaccine 

• Thousands of cancer patients to trial personalised vaccines 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.